Get startedLog in
    Picture of Deciphera Pharmaceuticals logo

    DCPH — Deciphera Pharmaceuticals Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Deciphera Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:10-K10-K10-K10-K10-K
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-192-266-300-179-195
    Depreciation
    Deferred Taxes
    Non-Cash Items17.438.455.354.847.7
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital24.8-13.90.82-32.4-1.54
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Taxes Payable
    Change in Other Liabilities
    Cash from Operating Activities-149-240-241-153-147
    Capital Expenditures-4.93-5.32-5.97-0.841-0.778
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-45633.8183-33.513.3
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Cash from Investing Activities-46128.5177-34.312.5
    Financing Cash Flow Items-0.62-0.815-0.04-0.425-0.634
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities43622714.9165152
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-17315.6-48.8-22.318.8